Hypertension · 2022 · 48 citations · 22 references
In patients with hypertension and mild cognitive impairment, angiotensin receptor blockers were associated with a lower risk of progression to dementia compared with ACE inhibitors and other classes of AHMs. Our findings may have important implications for clinical practice but still warrant further investigations in larger prospective cohorts or clinical trials.
22
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Thomas Unger, Claudio Borghi, Fadi J. Charchar et al. · Hypertension · 2020 · 3.9K citations · Full text
Alzheimer's Disease Neuroimaging Initiative (ADNI)
Ronald C. Petersen, Paul Aisen, Laurel Beckett et al. · Neurology · 2009 · 2.4K citations · Full text
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text
N.-C. Li, A. Lee, R. A. Whitmer et al. · BMJ · 2010 · 475 citations · Full text